지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Clozapine is an atypical antipsychotic agent that is more effective than the typical neuroleptics in the treatment of refractory schizophrenia. Recently, there has been an increased recognition of the association of clozapine with myocarditis and cardiomyopathy. Commonly used diagnostic tests have limited sensitivity in diagnosing this potentially life-threatening complication. Here we report a case of 36-year-old male patient who developed fever, tachycardia, and dyspnea after introduction of clozapine. By clinical evaluation and laboratory test we diagnosed the patient with myocarditis and treated him successfully. To our knowledge this is the first case report of clozapine-induced myocarditis in Korea.
목차
등록된 정보가 없습니다.
참고문헌 (33)
참고문헌 신청
Owens DG / 1996 / Adverse effects of antipsychotic agents. Do newer agents offer advantages? / Drugs 51:895~930
Conley RR / 1998 / Optimizing treatment with clozapine / J Clin Psychiatry 59(Suppl 3):44~48
McElroy SL / 1991 / Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia / J Clin Psychiatry 52:411~414
Suppes T / 1992 / Clozapine in the treatment of dysphoric mania / Biol Psychiatry 32:270~280
Meltzer HY / 1995 / Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on riskbenefit assessment / Am J Psychiatry 152:183~190
Conley RR / 1998 / Optimizing treatment with clozapine / J Clin Psychiatry 59(Suppl 3):44~48
McElroy SL / 1991 / Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia / J Clin Psychiatry 52:411~414
Suppes T / 1992 / Clozapine in the treatment of dysphoric mania / Biol Psychiatry 32:270~280
Meltzer HY / 1995 / Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on riskbenefit assessment / Am J Psychiatry 152:183~190
이 논문의 저자 정보
최근 본 자료
댓글(0)
0